Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.

NCT00326326 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer